Back to funds
View filing
Merck & Co., Inc.
institutionalUpdated 9 days agoManaged by Merck & Co., Inc. • Latest filing Q3 2026
Portfolio value
$820.3M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $276.3M |
| Q1 2026 | $349.4M |
| Q2 2026 | $526.4M |
| Q3 2026 | $820.3M |
Top holdings
13 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $444.5M | 2.31M | 54.18% | — | |
| 2 | $228.7M | 14.04M | 27.87% | — | |
| 3 | $86.3M | 772.2K | 10.52% | — | |
| 4 | $18.6M | 952.8K | 2.26% | — | |
| 5 | $13.4M | 1.67M | 1.63% | — | |
| 6 | $11M | 1.74M | 1.35% | — | |
| 7 | $6.6M | 3.55M | 0.80% | — | |
| 8 | ? N/A SUTRO BIOPHARMA INC | $4.4M | 272.4K | 0.53% | — |
| 9 | $4M | 1.21M | 0.49% | — | |
| 10 | $1.9M | 93.4K | 0.23% | — | |
| 11 | ? N/A XILIO THERAPEUTICS INC | $959K | 106.0K | 0.12% | — |
| 12 | ? N/A TUHURA BIOSCIENCES INC | $41K | 19.4K | 0.01% | — |
| 13 | $36K | 10.0K | 0.00% | — |